Generic Drugs Forum (GDF) 2024: Regulatory Considerations to Enhance Generic Drug Access APRIL 10 - 11, 2024

https://www.fda.gov/drugs/news-events-human-drugs/generic-drugs-forum-gdf-2024-regulatory-considerations-enhance-generic-drug-access-04102024?utm_medium=email&utm_source=govdelivery Generic Drugs Forum 2024: Regulatory Considerations to Enhance Generic Drug Access April 10-11, 2024 Experts from across FDA’s generic drug program will provide applicants with information on how to engage with the Agency and gain information about generic drug development and submitting high-quality abbreviated new drug applications (ANDAs) for assessment. Generic drug program leads will present resources, best practices, common deficiencies, policy updates, and opportunities to engage with the Agency from pre-ANDA to post-approval submissions.